Skip to content

A clinical study : Mental Health Care Application for Pregnant Women (Protocol No:NBP-24-01)

A randomized controlled study to evaluate the acceptability of a mental health care app for pregnant women and its effectiveness in improving depressive symptoms (Protocol No:NBP-24-01) - NBP-24-01

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056014
Enrollment
330
Registered
2024-11-11
Start date
2024-11-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First-time pregnant women aged 18 years or older and under 40 years old

Interventions

In this study, subjects in the app usage group are instructed to install the app on their own smartphones in accordance with the app installation support manual, and to use the app for approximately 5

Sponsors

Shionogi & Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Able to electronically obtain voluntary consent to participate in the study from the individual. 2. A primiparous woman aged 18 years or older and under 40 years old at the time of obtaining consent. 3. Between 16 and 28 weeks and 6 days pregnant at the time of obtaining consent. 4. Have a partner or spouse, including a common-law marriage. 5. Have basic reading and writing skills in Japanese and can use the app and answer questionnaires without any problems.

Exclusion criteria

Exclusion criteria: 1. Currently receiving treatment at a psychiatric or psychosomatic clinic (regardless of past medical history) 2. Pre-screening PHQ-9 score of 2 or more on item 9 of the PHQ-9 questionnaire indicates suicidal ideation 3. Not having a partner or spouse, or pregnant with someone other than a partner or spouse 4. Other cases where a medical advisor has determined that participation in this study is inappropriate based on concomitant medications or medical findings

Design outcomes

Primary

MeasureTime frame
Proportion of subjects in the intervention group with moderate to high satisfaction (CSQ-8J score is 17 or more) at Visit 5 (CSQ-8J administered only in the intervention group) Change in PHQ-9 score from baseline at Visit 5

Secondary

MeasureTime frame
Percentage of subjects showing medium to high satisfaction level (CSQ-8J score is 17 or more) at Visit 6 Change in CSQ-8 score at Visit 6 from Visit 5 Change in PHQ-9 score from baseline at Visit 2, Visit 3, Visit 4, Visit 5, and Visit 6 Amount of change in EPDS score from baseline at Visit 5 and Visit 6 Change in ECR-RS score from baseline at Visit 5 and Visit 6

Countries

Japan

Contacts

Public ContactShinsuke Asao

Integrity Healthcare Co., Ltd. Digital Therapy Business Department

admin_studyformaternity@integrity-healthcare.co.jp0366610858

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026